T cells in HBV associated hepatocellular carcinoma and other cancers
<p>Individuals with HBV associated hepatocellular carcinoma or other cancers are characterized by dysfunctional anti-virus and anti-tumor T-cell responses. Since noteworthy benefits of inhibitory pathway blockades, such as PD-1 inhibitor or CTLA-4 inhibitor have been achieved in multiple advan...
Tác giả chính: | Li, X |
---|---|
Tác giả khác: | Dong, T |
Định dạng: | Luận văn |
Được phát hành: |
2017
|
Những quyển sách tương tự
-
Proteomics-related biomarkers for HBV-associated hepatocellular carcinoma : current status and future prospects
Bằng: Sadrolodabaee, Laleh, et al.
Được phát hành: (2013) -
Epigenetic analysis of hepatocellular carcinoma development : involvement of HBV-modulated DNA methylation
Bằng: Niu, Dandan
Được phát hành: (2010) -
Smart detectives for early detection of hepatocellular carcinoma related to drug-resistant HBV-mutant infection.
Bằng: Lee, Kar Kei.
Được phát hành: (2010) -
Dendritic cell vaccination for hepatocellular carcinoma.
Bằng: Midgley, R, et al.
Được phát hành: (2003) -
Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
Bằng: Sun, Z, et al.
Được phát hành: (1991)